Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices 44631 

rapidly adapted for targeted information 

collection that would not be feasible 

with other surveillance methods. 

The burden estimate for PRAMS 

includes two types of information 

collection: (1) Information collection 

associated with the PRAMS core 

questions and predetermined standard 

questions from optional modules, and 

(2) information collection associated 

with optional modules for emerging 

issues. Participation is voluntary and 

there are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Types of 

respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average hours 

per response 

(in hours) 

Total burden 

hours 

Women who recently delivered a live 

birth.

PRAMS Phase 8 Core Questions .... 62,514 1 25/60 26,048 

PRAMS Standard Questions on optional modules—predetermined.62,514 1 10/60 10,419 

Estimated burden hours for additional optional modules—emerging.32,530 1 7/60 3,795 

Total ........................................... ........................................................... ........................ ........................ ........................ 40,262 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–19014 Filed 8–30–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–0800] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Focus Group 

Testing to Effectively Plan and Tailor 

Cancer Prevention and Control 

Communication Campaigns to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on December 

13, 2017 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communication Campaigns— 

(OMB No. 0920–0800, exp. 12/31/ 

2017)—Reinstatement without Change— 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

CDC requests a reinstatement of the 

information collection with OMB 

Control Number 0920–0800. The 

mission of the CDC’s Division of Cancer 

Prevention and Control (DCPC) is to 

reduce the burden of cancer in the 

United States through cancer 

prevention, reduction of risk, early 

detection, better treatment, and 

improved quality of life for cancer 

survivors. Toward this end, the DCPC 

supports the scientific development and 

implementation of various health 

communication campaigns with an 

emphasis on specific cancer burdens. 

This process requires testing of 

messages, concepts, and materials prior 

to their final development and 

dissemination, as described in the 

second step of the health 

communication process. The health 

communication process is a scientific 

model developed by the U.S. 

Department of Health and Human 

Services’ National Cancer Institute to 

guide sound campaign development. 

The communication literature supports 

various data collection methods, one of 

which is focus groups, to conduct 

credible formative, concept, message, 

and materials testing. The purpose of 

focus groups is to ensure that the public 

and other key audiences, like health 

professionals, clearly understand 

cancer-specific information and 

concepts, are motivated to take the 

desired action, and do not react 

negatively to the messages. CDC is 

currently approved to collect 

information needed to plan and tailor 

cancer communication campaigns (OMB 

No. 0920–0800, exp. 12/31/2017), and 

seeks OMB approval to reinstate this 

generic clearance. 

Information collection will involve 

focus groups to assess numerous 


daltland on DSKBBV9HB2PROD with NOTICES
44632 Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices 

qualitative dimensions of cancer 

prevention and control messages 

including, but not limited to, cancer 

knowledge, attitudes, beliefs, behavioral 

intentions, information needs and 

sources, clinical practices (among 

healthcare providers), and compliance 

with recommended cancer screening. 

Insights gained from the focus groups 

will assist in the development and/or 

refinement of future campaign messages 

and materials. Respondents will include 

healthcare providers as well as members 

of the general public. Communication 

campaigns and messages will vary 

according to the type of cancer, the 

qualitative dimensions of the message 

described above, and the type of 

respondents. 

DCPC plans to conduct or sponsor up 

to 80 focus groups per year over a threeyear period. An average of 10 

respondents will participate in each 

focus group discussion. DCPC has 

developed a set of example questions 

that can be used to develop a discussion 

guide for each focus group activity. The 

average burden for response for each 

focus group will be two hours. DCPC 

has also developed a set of example 

questions that can be tailored to screen 

for targeted groups of respondents. The 

average burden per response for 

screening and recruitment is three 

minutes. A separate information 

collection request will be submitted to 

OMB for approval of each focus group 

activity. The request will describe the 

purpose of the activity and include the 

customized information collection 

instruments. 

OMB approval is requested for three 

years. There are no changes to 

information collection purpose or 

methodology. Annual estimated Burden 

Hours are 1,680. Participation is 

voluntary and there are no costs to 

respondents except their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hr) 

General Public ................................................ Screening Form .............................................. 960 1 3/60 

General Public ................................................ Focus Group Guide ........................................ 480 1 2 

Health Care Professionals .............................. Screening Form .............................................. 640 1 3/60 

Health Care Professionals .............................. Focus Group Guide ........................................ 320 1 2 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–19013 Filed 8–30–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7051–N] 

Medicare & Medicaid Programs, and 

Other Program Initiatives, and 

Priorities; Meeting of the Advisory 

Panel on Outreach and Education 

(APOE), September 26, 2018 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

next meeting of the Advisory Panel on 

Outreach and Education (APOE) (the 

Panel) in accordance with the Federal 

Advisory Committee Act. The Panel 

advises and makes recommendations to 

the Secretary of the U.S. Department of 

Health and Human Services (HHS) and 

the Administrator of the Centers for 

Medicare & Medicaid Services (CMS) on 

opportunities to enhance the 

effectiveness of consumer education 

strategies concerning CMS programs, 

initiatives and priorities. This meeting 

is open to the public. 

DATES:

Meeting Date: Wednesday, September 

26, 2018 8:30 a.m. to 4 p.m. eastern 

daylight time (e.d.t). 

Deadline for Meeting Registration, 

Presentations, Special Accommodations 

and Comments: Wednesday, September 

12, 2018, 5 p.m., e.d.t. 

ADDRESSES: 

Meeting Location: U.S. Department of 

Health & Human Services, Hubert H. 

Humphrey Building, 200 Independence 

Avenue SW, Room 502A, Conference 

Room, Washington, DC 20201. 

Presentations and Written Comments: 

Presentations and written comments 

should be submitted to: Lynne Johnson, 

Acting Designated Federal Official 

(DFO), Office of Communications, 

Centers for Medicare & Medicaid 

Services, 7500 Security Boulevard, 

Mailstop S1–05–06, Baltimore, MD 

21244–1850 or via email at 

Lynne.Johnson@cms.hhs.gov. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register at the 

website https://www.regonline.com/ 

apoe2018sept26meeting/ or by 

contacting the Acting DFO listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice, by the date listed 

in the DATES section of this notice. 

Individuals requiring sign language 

interpretation or other special 

accommodations should contact the 

Acting DFO at the address listed in the 

ADDRESSES section of this notice by the 

date listed in the DATES section of this 

notice. 

FOR FURTHER INFORMATION CONTACT: 

Lynne Johnson, Acting Designated 

Federal Official, Office of 

Communications, CMS, 7500 Security 

Boulevard, Mail Stop S1–05–06, 

Baltimore, MD 21244–1850, 410–786– 

0090, email Lynne.Johnson@

cms.hhs.gov. Additional information 

about the APOE is available on the 

internet at: http://www.cms.gov/ 

Regulations-and-guidance/Guidance/ 

FACA/APOE.html. Press inquiries are 

handled through the CMS Press Office 

at (202) 690–6145. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Advisory Panel for Outreach and 

Education (APOE) (the Panel) is 

governed by the provisions of Federal 

Advisory Committee Act (FACA) (Pub. 

L. 92–463), as amended (5 U.S.C. 

Appendix 2), which sets forth standards 

for the formation and use of federal 

advisory committees. The Panel is 

authorized by section 1114(f) of the 

Social Security Act (42 U.S.C. 1314(f)) 

and section 222 of the Public Health 

Service Act (42 U.S.C. 217a). 

The Secretary of the U.S. Department 

of Health and Human Services (HHS) 

(the Secretary) signed the charter 

establishing the Citizen’s Advisory 


daltland on DSKBBV9HB2PROD with NOTICES